Tax Dodger Apple Te...
Health Care: Drugs
Novogen Ltd. (NVGN: NASDAQ)
$3.98 -0.05 | -1.24%
05/21/13 - 11:59 AM ET
937.00 / 222.40K
Vol / Avg. Vol:3.98 / 4.03
Open / Prev. Close:3.98 - 4.03
Today's Range:1.47 - 10.49
52 Wk Range:-41.87%
Performance YTD:TheStreet Rating:
Portfolios with NVGN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- Userscjs4r speculative
Latest NVGN Headlines from TheStreet
- 5 Stocks Poised to Break Out 05.10.13 | 02:05 pm
- Tiny Biotechs Dancing in the Bull Pen 05.20.09 | 12:05 pm
- Monday's Health Winners & Losers 09.18.06 | 03:09 pm
- Friday's Health Winners & Losers 08.25.06 | 03:08 pm
- Health Stocks in Motion 07.06.04 | 05:07 pm
Press Releases for NVGN
- As Released On 30 December, 2011: Novogen Modifies ADR Program And Makes Further Investment Into Marshall Edwards - PR Newswire 01.04.12 | 05:01 pm
- Glycotex, Inc. Awarded Cash Grant Under The U.S. Government Qualifying Therapeutic Discovery Program - PR Newswire 11.24.10 | 08:11 am
- Marshall Edwards Reaches Agreement In Principle To Acquire Intellectual Property Portfolio From Novogen - PR Newswire 09.08.10 | 08:09 am
- Marshall Edwards To Host Conference Call On September 8, 2010 - PR Newswire 08.31.10 | 09:08 am
- Marshall Edwards Appoints Oncologist Christine White To Board Of Directors - PR Newswire 08.10.10 | 07:08 am
Partner Headlines for NVGN
- Morning Market Movers - Benzinga 04.03.13 | 09:04 am
- On January 3rd, Novogen to Change ADR Conversion Ratio, Similar to a 5:1 Reverse Stock Split - Benzinga 12.29.11 | 01:12 pm
- Top Buy and Sell Ideas Based on Wednesday's Biggest Gainers - Seeking Alpha 07.28.11 | 09:07 am
